Pages

.

Showing posts with label Impact. Show all posts
Showing posts with label Impact. Show all posts

Triax Technologies and Washington Youth Soccer Champion Head Impact Monitoring

Norwalk, CT and TUKWILA, WA - January 8, 2015 Triax Technologies Inc and Washington Youth Soccer have announced a long-term partnership to track and assess head impacts among top level youth players. Findings from the large scale collection of data will be used to identify trends and potential risks to inform training protocols which will be publically shared to encourage best practices.Read More

Players from the Washington Youth Soccer Elite Player Development (EPD) program (U12-U18) will wear the Triax Technologies Smart Impact Monitors (SIM™) as they compete in the prestigious US Youth Soccer Region IV Olympic Development Program (ODP) Championships January 8–11 in Phoenix, AZ, and will continue throughout their careers with Washington Youth Soccer.

Triax SIM™ devices are worn in comfortable, unobtrusive headbands to record head impacts, and transmit data in real time from the field to a smart phone or tablet on the sideline. This cutting edge technology allows players to track up to 180 individual head impacts measuring the G–force of direct hits and jarring through linear and rotational measures.

The SIM allows coaches, trainers and parents to identify when a player has experienced a significant head impact or a series of repetitive “sub–concussive” hits that might require altering technique or removal from play for assessment.

“After my recent visit with some of the Washington players, it’s exciting to see the state EDP program taking this important step in safety,” said Abby Wambach, U.S. Women’s National Team and all-time high-goal scorer. “I encourage these players to use the Triax SIM in their training beyond this tournament, just as I am doing in my own training heading into this summer’s World Cup.”

The first device of its kind to be Hit Count® certified in all sports categories as defined by the Sports Legacy Institute, Triax SIM devices are currently being used or evaluated for use with 18 institutions and universities around the country as part of various research projects. These studies will help to better understand sports related concussions and the impact of sub–concussive hits. And now, the data from the Washington Youth Soccer players will add to the new and emerging learnings about head impacts, and will be specifically used to educate players and coaches.

“The benefits gained from this partnership will continue far beyond the tournament,” said Dale Hollingsworth, CEO and Founder of Triax Technologies. “Our goal is to improve player safety. And now, with Washington Youth Soccer, we are championing new research that will lead to safer training and more informed decision-making.”

The Washington Youth Soccer EPD players began wearing the Triax SIM devices during trainings leading into the US Youth Soccer Region IV ODP Championships, where the top players from each Western state will compete. The players will continue to wear the devices in competition throughout the event and in trainings and future competitions. In addition to providing valuable information on the players during play, the SIM data gathered from these players will also be used to evaluate trends and glean lessons to foster better understanding of head impact risk and management.

“For the last seven years, Washington Youth Soccer has been driving change in how head impacts are regarded by our nation’s youth sports communities. Now, with the new ability to accurately quantify impacts, we are able to help define where adjustments could be made to play or technique for player safety,” states Washington Youth Soccer CEO, Terry Fisher. “We are committed to providing young athletes with the safest environment possible and look forward to seeing the findings these data will provide.”

Washington Youth Soccer has been a leader in implementing proper concussion protocols and awareness, driving adoption throughout US Youth Soccer, and building support at the congressional level. This partnership with Triax Technologies is a natural extension of the organizations ongoing commitment to player safety. For more information on Triax Technologies, visit TriaxTec.com.

###

Triax Technologies Inc
Triax Technologies Inc is a U.S.–based product development company committed to setting new standards in the health and wellbeing of athletes. Working together with leading research institutions, we innovate, develop, manufacture and market new products that are designed specifically to meet emerging needs of athletes and those who are involved in ensuring their health and safety. Our goal is to put players first and support their development starting at the youth level by developing technology to address their needs. For more information, please visit www.TriaxTec.com.

About Washington Youth Soccer
Washington Youth Soccer is the largest youth soccer organization in Washington and is the state's affiliate for US Youth Soccer, the largest youth sports organization in the United States and the most populous member of the United States Soccer Federation, the governing body for soccer in the United States. Washington Youth Soccer is the 10th largest membership in the nation; representing over 105,000 players (ages 4–19) and their families, 15,000 coaches on 12,000 teams and 6,500 referees in the state of Washington. Washington Youth Soccer’s mission is to foster the physical, mental and emotional growth and development of the State of Washington's youth through the sport of soccer at all levels of age and competition. To learn more visit WashingtonYouthSoccer.org.

Media Request: When referring to Washington Youth Soccer, please refer to the association only as Washington Youth Soccer, and never as WYS or WSYSA. We appreciate your cooperation.

reade more... Résuméabuiyad

Pressure BioSciences, Inc. Selected to Present at Cavendish Global Health Impact Forum

SOUTH EASTON, Mass., May 5, 2014 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a worldwide leader in the development and sale of high pressure-based sample preparation systems to the life sciences research market, today announced that it has been selected to present at the Cavendish Global Health Impact Forum taking place May 5-7 New York, NY.  The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences.  To accomplish this mission, the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts, and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis, and treatment.

Mr. Michael Moffat, Cavendish co-founder and President explains, "With the help of our expert advisors, we conducted a global search of research institutions and private-sector companies to identify organizations that meet the required standard of excellence.  The quality and originality of Pressure BioSciences' broadly enabling pressure cycling technology (PCT) platform positions them to make major contributions in supporting thousands of researchers around the world in their efforts to identify, control, prevent, and cure a host of diseases and disorders afflicting humans, animals, and plants."

"We are honored to be selected to present at this unique event, as we believe it is further recognition of the importance of our powerful and innovative PCT platform," said Mr. Richard T. Schumacher, President and CEO of PBI.  "Over 100 publications now cite the advantages of the PCT System in the development of improved testing methods to enhance the health and well-being of people worldwide.  These methods are used in areas such as (i) human disease and disorders, (ii) forensics, (iii) food safety, and (iv) agriculture.  We welcome the opportunity to interact with many of world's leading scientific minds, thought-leaders, and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people worldwide."

Cavendish Global consists of over 150 leading family offices and foundations from around the world with combined assets of over $190 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making, and impact investing.  The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world.  Cavendish Global, together with the Global Partnerships Forum and the New York Academy of Sciences, organizes the Forum annually in New York.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.      

Further information is available on the Company's website: http://www.pressurebiosciences.com

About Cavendish Global

Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment, grant making and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums.  A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year; in the United States (taking place in New York at the United Nations Headquarters May 5th to 7th 2014), Europe (London, October 2014) and a third event held at a Cavendish Host Partner City which moves to a different global location each year (Dubai, UAE January 2015).

For more information: http://cavendishglobal.com

Forward Looking Statements

Statements contained in this press release regarding PBI's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Investor Contacts:

Richard T. Schumacher, President and CEO                           (508) 230-1828 (T)
Richard P. Thomley, CFO                                                      (508) 230-1829 (F)
Howard Gostfrand, President, American Capital Ventures         (305) 918-7000 (T)

SOURCE Pressure BioSciences, Inc.

RELATED LINKS
http://www.pressurebiosciences.com

reade more... Résuméabuiyad